Testosterone Treatment Lawsuits Continue As Study Links Heart Attacks To Low-T Therapy

Print

Testosterone Treatment Lawsuits Allege Makers of Low-T Drugs Failed To Warn That Their Products May Cause Stroke, Heart Attack And Cardiac Death.

Low-Testosterone-Drug-Lawsuits-Wright-and-Schulte-LLCTestosterone Treatment Lawsuits: A pair of recently published studies suggest the testosterone hormone and testosterone replacement therapy place men at a higher risk of heart attack, stroke and death. At the same time, testosterone treatment lawsuits continue to be filed against testosterone manufacturers that allege their products, including AndroGel and Androderm, can cause heart attack, stroke, blood clots and cardiac death. (In re: Testosterone Replacement Therapy Product Liability Litigation – MDL No. 2545)

Low Testosterone Drug Studies

A Canadian testosterone treatment study followed 38,340 men, aged 66 years or older, from January 1, 2007 to June 30, 2012. Of the total, 10,311 men were given testosterone replacement therapy while 28,029 men in a control group that was not given testosterone drugs. Researchers found that men who received testosterone replacement therapy were at an increase risk of heart attack, stroke or death in the first two or three months of treatment compared to the control group. By contrast, men who continued testosterone treatment for three to five years were at a reduced risk of cardiovascular events. The study was published in the June 2016 issue of The Lancet medical journal.
[thelancet.com/journals/landia/article/PIIS2213-8587(16)00112-1/abstract, The Lancet, June 2016]

In the second low testosterone therapy study, researchers in the UK looked at the link between testosterone and heart disease. Scientists found that testosterone in mice triggered cells from the blood vessel to produce bone-like deposits, a process called calcification. When testosterone receptors were removed, the mouse cells produced far less of the calcium deposits. Researchers examined blood vessel and valve tissue from humans with heart disease and discovered that cells from the tissues contained calcification and carried the testosterone receptor on their surface. Scientists said this suggests that testosterone may trigger calcification in humans. Calcification causes hardening of the arteries and is associated with an increased risk of heart attack and stroke because it can prevent heart valves from opening and shutting properly. The study was published in the journal Scientific Reports in April 2016.
[bbsrc.ac.uk/news/health/2016/160421-pr-research-links-heart-disease-with-testosterone/, BBSRC, April 21, 2016]

FDA Requires Warning Testosterone Drugs May Cause Increased Risk Of Heart Attacks and Strokes

In January 2014, the FDA launched an investigation into all FDA-approved testosterone creams, gels, and injections such as AdroGel, Androderm and Testim. As a result of their investigation, in March 2015, the FDA required testosterone makers to add information on their product labels about a possible increased risk of heart attacks and strokes in patients taking testosterone replacement therapy drugs. Testosterone replacement therapy drugs, such as Testim and Fortesta, are approved by the U.S. Food and Drug Administration (FDA) to treat hypogonadism, which is low testosterone levels in men caused by a medical condition and not due to aging.
[fda.gov/Drugs/DrugSafety/ucm383904.htm, January 31, 2014]

Testosterone Treatment Lawsuits

Six months after the FDA announced its investigation, a multidistrict litigation (MDL) was established in the U.S. District Court, Northern District of Illinois for all federally filed testosterone complaints. Wright & Schulte LLC is representing plaintiffs in the MDL. Men or their survivors, who believe they have experienced cardiac events due to testosterone therapy drugs, may contact one of the firm’s attorneys for a free lawsuit evaluation by calling 1-800-399-0795 or visit www.yourlegalhelp.com.

According to court documents, the six testosterone manufacturers involved in the MDL are:

• AbbVie and Abbott Laboratories, which makes and markets AndroGel
•Actavis, Inc. and Watson Pharmaceuticals, which makes AndroDerm
•Auxilium Pharmaceuticals, Inc., which makes Testim
•Eli Lilly and Company and Lilly USA LLC, makers of Axiron
•Pharmaceuticals Inc., which makes Delatestryl and Fortesta
• Pfizer Inc. and its subsidiary, Pharmacia & Upjohn Co. which makes and markets Depo-Testosterone
(In re: Testosterone Replacement Therapy ProductLiabilityLitigation – MDL No. 2545)

About Wright & Schulte LLC And Filing A Testosterone Treatment Lawsuit

Wright & Schulte LLC, an experienced personal injury firm, is dedicated to the belief that America’s legal system should work for the people. Every day, the attorneys of Wright Schulte LLC stand up for the rights of people who have been injured or wronged, and fight tirelessly to ensure that even the world’s most powerful corporations take responsibility for their actions. If you’re looking for a law firm that will guarantee the aggressive and personal representation you deserve, please do not hesitate to contact Wright & Schulte LLC today. Free testosterone lawsuit case evaluations are available through yourlegalhelp.com, or call 1-888-399-0795.

Contact:
Wright & Schulte LLC
865 S. Dixie Dr.
Vandalia, Ohio 45377
1-800-399-0795
http://www.yourlegalhelp.com

This entry was posted in Wright & Schulte Lawsuit News. Bookmark the permalink.